One of the most compelling reasons international patients choose CAR-T therapy in China is the substantial cost savings without compromising treatment quality:
Cost Component | United States | China (SaiAo Biotech) |
CAR-T Product Cost | $373,000 - $475,000 | $80,000 - $100,000 |
Hospitalization & Care | $50,000 - $100,000 | $30,000 - $40,000 |
Total Estimated Cost | $423,000 - $575,000 | $110,000 - $140,000 |
Total Savings: Patients can achieve cost savings of approximately $300,000–$450,000 compared to U.S. treatment benchmarks, while receiving care of comparable or superior quality.
China leads globally in CAR-T clinical research volume, publication output, and cumulative treatment experience
https://doi.org/10.1186/s40364-026-00910-6
Nanfang-Chunfu Institute of Hematology & Oncology has treated thousands of CAR-T patients with extensive expertise
Proven track record in managing treatment-related side effects including CRS and ICANS
Access to next-generation CAR-T technologies and innovative clinical trials
Multidisciplinary medical teams with international training from top US and European institutions
English-speaking physicians and nursing staff experienced in caring for international patients
Dedicated bilingual medical coordinators assigned to each patient
Professional medical interpreters for all consultations and procedures
Visa application assistance with official invitation letters from the hospital
Airport pickup and transportation services throughout treatment
Assistance with accommodation arrangements near treatment facilities
24/7 emergency contact and support hotline
Post-treatment follow-up care coordination with home country physicians
Cultural and dietary support for international patients
Initial Remote Consultation: Free video consultation with our medical team, review of medical records and imaging, assessment of treatment eligibility, preliminary treatment plan and cost estimate.
Treatment Planning & Coordination: Detailed treatment protocol development, timeline scheduling, coordination with Southern Spring Fortune Hematology Research Institute, preparation of medical invitation letter for visa application.
Travel Preparation: Visa application guidance, flight booking assistance, accommodation recommendations (hospital-affiliated hotels or serviced apartments), travel insurance guidance.
Arrival & Initial Assessment: Airport pickup service, hospital admission, comprehensive medical evaluation including physical examination, laboratory tests, and imaging studies, final treatment plan confirmation.
Cell Collection (Leukapheresis): T cell collection procedure (Day 1), typically takes 3-4 hours, patient can return to accommodation same day.
Manufacturing Period: CAR-T cell production (7-10 days), patient may choose to return home during this period or stay in Guangzhou for sightseeing/recovery.
Lymphodepletion: Preparatory chemotherapy (3 days) to optimize the body for CAR-T cell infusion, inpatient or outpatient depending on patient condition.
CAR-T Infusion: Day 0: CAR-T cell infusion via IV, typically takes 30-60 minutes, observation period in hospital.
Monitoring & Recovery: In-hospital observation for 2-4 weeks, daily monitoring for CRS and neurotoxicity, supportive care as needed, gradual recovery and rehabilitation.
Discharge & Follow-up: Discharge planning with detailed instructions, return travel arrangements, remote follow-up appointments, coordination with home country physicians for long-term monitoring.
